This study was done to evaluate whether cardiac dysfunction or abnormal measurements on cardiopulmonary exercise testing (CPET) can be improved after 2 months of nasal CPAP treatment. Twenty patients with moderate or severe OSAS received nasal CPAP treatment. All subjects also underwent blood pressure, simple spirometric, and arterial blood gas (ABG) measurements; cardiac evaluation by radionuclide scanning and CPET; and an overnight polysomnography sleep study before and after nasal CPAP treatment. No difference in left ventricular ejection fraction (LVEF) was found after 2 months of nasal CPAP treatment, but higher right ventricular ejection fraction (RVEF), VO2peak, VO2peak/kg and workpeak were observed. After 2 months of nasal CPAP treatment, these patients had a lower breathing reserve and a greater increase in anaerobic threshold and oxygen pulse. Moderate to severe OSAS patients before nasal CPAP treatment had abnormal CPET as reflected by lower RVEF, VO2peak/kg, workpeak, anaerobic threshold and oxygen pulse. These abnormalities can be improved after 2 months of nasal CPAP treatment.

No abstract

No abstract

Managing the airway of patients with craniofacial abnormalities can potentially be difficult. It should be carried out by experienced anesthesiologists, with assistance from an otolaryngologist when necessary. A variety of different airway devices should be available if needed.

No abstract

Successful treatment of OSAS with UPPP leads to restoration of FMD and normal serum levels of NO(x).

We demonstrated a protrusion‐less MVA‐LCD (AMVA‐mobile) with fast switching response of 8 ms (on) and contrast ratio over 600:1. High performance is attributed to use an effective polymer alignment layer and improvements in optical optimization and curing process.

No abstract